within Pharmacolibrary.Drugs.ATC.C;

model C01EB17
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.001,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.1,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006,
    Tlag           = 900,            
    Vdp             = 0.2,
    k12             = 120,
    k21             = 120
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01EB17</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ivabradine is a selective inhibitor of the cardiac pacemaker If current, reducing heart rate without affecting myocardial contractility or intracardiac conduction. It is used for the symptomatic treatment of chronic stable angina pectoris and chronic heart failure. Ivabradine is approved in many countries for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult subjects after oral administration of ivabradine 10 mg single dose.</p><h4>References</h4><ol><li><p>Riesen, SC, et al., &amp; Schober, KE (2011). Pharmacokinetics of oral ivabradine in healthy cats. <i>Journal of veterinary pharmacology and therapeutics</i> 34(5) 469–475. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.2010.01253.x&quot;>10.1111/j.1365-2885.2010.01253.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21118419/&quot;>https://pubmed.ncbi.nlm.nih.gov/21118419</a></p></li><li><p>Chen, XP, et al., &amp; Hu, J (2015). The Effect of Silibinin on the Pharmacokinetics of Ivabradine and N-Desmethylivabradine in Rats. <i>Pharmacology</i> 96(3-4) 107–111. DOI:<a href=&quot;https://doi.org/10.1159/000435890&quot;>10.1159/000435890</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26202095/&quot;>https://pubmed.ncbi.nlm.nih.gov/26202095</a></p></li><li><p>Petite, SE, et al., &amp; Mauro, VF (2018). Role of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review. <i>American journal of therapeutics</i> 25(2) e247–e266. DOI:<a href=&quot;https://doi.org/10.1097/MJT.0000000000000388&quot;>10.1097/MJT.0000000000000388</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26910057/&quot;>https://pubmed.ncbi.nlm.nih.gov/26910057</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01EB17;
